152-11-4 (盐酸维拉帕米,Verapamil hydrochloride)

盐酸维拉帕米;alpha-[3-[[2-(3,4-二甲氧苯基)乙基]甲氨基]丙基]-alpha-异丙基-3,4-二甲氧基苯乙腈盐酸盐;维拉帕米盐酸盐;戊脉安 盐酸盐;异搏定 盐酸盐;异搏停 盐酸盐;Verapamil Hydrochloride 维拉帕米盐酸盐;盐酸维拉帕米 EP标准品;盐酸维拉帕米 USP标准品;盐酸维拉帕米 标准品;盐酸维拉帕米、维拉帕米盐酸盐;盐酸维拉帕米杂质对照品;盐酸盐维拉帕米 标准品;Α-[3-[[2-(3,4-二甲氧苯基)乙基]甲氨基]丙基]-Α-异丙基-3,4-二甲氧基苯乙腈盐酸盐;苯噻嗪;维拉帕米,盐酸D7;盐酸维拉帕米,(±)-Verapamil hydrochloride;5-[(3,4-二甲氧基苯乙基)甲氨基]-2-(3,4-二甲氧基苯基)-2-异丙基戊腈盐酸盐;戊脉安;维拉帕米盐酸;盐酸维拉帕米(标准品);盐酸维拉帕米, 一种L型钙通道阻断剂;盐酸维拉帕米 戊脉安;

VERAPAMIL HYDROCHLORIDE;alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-;benzeneacetonitrile hydrochloride;5-[(3,4-DIMETHOXYPHENETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYL-VALERONITRILE HYDROCHLORIDE (+/-)-VERAPAMIL HYDROCHLORIDE;CALAN;IPROVERATRIL;ISOPTIN;(+/-)-5-[N-(3,4-DIMETHOXYPHENYLETHYL)-METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE;5-[N-(3,4-DIMETHOXYPHENYLETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE;alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-benzeneacetonitrile hydrochloride;ALPHA-[3-[[2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO]PROPYL]-3,4-DIMETHOXY-ALPHA-(1-METHYLETHYL)BENZENEACETONITRILE HYDROCHLORIDE;5-[(3,4-DIMETHOXYPHENETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYL-VALERONITRILE HYDROCHLORIDE;Verapamil HCl;finoptin;iproveratrilhydrochloride;izoptinhydrochloride;(±)-Verapamil hydrochloride;(+-)-VERAPAMIL HYDROCHLORIDE;(±)-Verapamil hydrochlorid;2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)-ethyl](methyl)amino]-2-isopropylpentanenitrile hydrochloride;Verapamil (hydrochloride);Verapamil Hydrochlor;Verapamil hydrochloride solution;(+/-)-Verapamil hydrochloride;(-)-VerapaMil hydrochloride;(‘±)-Verapamil hydrochloride;Verapamil hydrochloride,α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)benzeneacetonitrilehydrochloride;5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile Hydrochloride;5-[N-(3,4-Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2;manidon;lu20175;Rositol;cordilox;Hormitol;Magotiron;Verapamil HCI;d-365hydrochloride;verapamilchloridrate;Calcan hydrochloride;Cardibeltin;Veroptinstada;Cardioprotect;Cardiabeltin;Vetrimil;Vasopten;Vasomil;Jenapamil;Isoptino;Corpamil;Coraver;Caveril;Veratensin;Verasal;Veraloc;Veracor;Verabeta;Praecicor;Hexasoptin;Verasifar;Veramil;Ikapress;Harteze;Durasoptin;Civicor;Calaptin;Verdilac;Verapin;Verahexal;Robatelan;Lodixal;Inselon;Flamon;Elthon;Vortac;Univex;Ikacor;Rapam;Anpec;Ormil;Verapamil;CP-16533-1 hydrochloride;Verapamil Basics;VERAPAMIL HYDROCHLORIDE [USAN];Q27291481;D-365 hydrochloride;Verapamil chloridrate;MLS002222213;(+-)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride;?VERAPAMIL HYDROCHLORIDE;Calan (TN);NS00079093;Quasar;D78147;VERAPAMIL HYDROCHLORIDE (EP MONOGRAPH);VERAPAMIL HYDROCHLORIDE (EP IMPURITY);D00619;MLS000069485;( inverted exclamation markA)-Verapamil hydrochlorid;Verelan;Isotopin hydrochloride;Novapamyl LP;AS-16018;( inverted question mark)-Verapamil hydrochloride;NCGC00024710-03;SR-01000000050-2;NSC-759589;?-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-?-(1-methylethyl)benzeneacetonitrile hydrochloride;BENZENEACETONITRILE, alpha-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4-DIMETHOXY-alpha-(1-METHYLETHYL)-, MONOHYDROCHLORIDE, (+/-)-;Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (+-)-;NSC657799;SY073165;A816666;(+/-)-Verapamil, Hydrochloride - CAS 152-11-4;CHEBI:53188;5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride;23313-68-0;Veracaps SR;(+/-)-Verapamil hydrochloride, >=99% (titration), powder;NSC272366;alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl) benzeneacetonitrile hydrochloride;VERAPAMIL HYDROCHLORIDE [MART.];FT-0675800;Q-201923;VERAPAMIL HYDROCHLORIDE [WHO-IP];5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrilehydrochloride;(?)-Verapamil hydrochloride;EINECS 205-800-5;NSC 272366;AC-8483;Verapamil Nordic;V 4629;Dilacoran HTA;152-11-4;Pharmakon1600-02300307;Verapress 240 SR;Prestwick_440;LU-20175;VERAPAMIL HYDROCHLORIDE (USP MONOGRAPH);BCP06465;NCGC00261922-01;CAS-152-11-4;EN300-124002;DTXCID0014095;VERAPAMIL HYDROCHLORIDE [HSDB];MFCD00055208;VERAPAMIL HYDROCHLORIDE (MART.);HMS1568M04;Verapamil SR;rac-4-cyano-4-(3,4-dimethoxyphenyl)-N-(2-(3,4-dimethoxyphenyl)ethyl)-N,5-dimethylhexan-1-aminium chloride;NSC-657799;AKOS005267117;SR-01000000050-4;Cardiagutt;HMS1922J16;VERAPAMIL HYDROCHLORIDE [EP MONOGRAPH];Verapamil Henning;Verapamili hydrochloridum;Apo-Verap;Verelan SR;Hexasoptin Retard;Tox21_201180;Covera;verapamil.hcl;Verapamil Verla;(+/-)-5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride;s4202;Calaptin 240 SR;DOQPXTMNIUCOSY-UHFFFAOYSA-N;Tox21_501237;2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-propan-2-yl-pentanenitrile hydrochloride;NCGC00094479-05;Arpamyl LP;SR-01000000050;Verapamil Riker;MLS001055442;FT-0603360;Nu-Verap;Vasolan (TN);Isoptin Retard;Benzeneacetonitrile,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride;Verelan PM;Verapamil Hydrochloride,(S);Covera-HS;NCGC00094479-02;Verapamil Acis;NCGC00094479-03;VERAPAMIL HYDROCHLORIDE [WHO-DD];VERAPAMIL HYDROCHLORIDE [ORANGE BOOK];Verapamil Injection;SMR000059109;Verapamil PB;V3888OEY5R;NCGC00258732-01;2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride;Verapamil hydrochloride, United States Pharmacopeia (USP) Reference Standard;VERAPAMIL HYDROCHLORIDE [USP MONOGRAPH];Opera_ID_1210;V0118;Izoptin;Verapamil Hydrochloride 1.0 mg/ml in Methanol (as free base);UNII-V3888OEY5R;BENZENEACETONITRILE, .ALPHA.-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4-DIMETHOXY-.ALPHA.-(1-METHYLETHYL)-, MONOHYDROCHLORIDE, (+/-)-;SPECTRUM2300307;Calan SR;Verapamil Ebewe;2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile hydrochloride;Cordilox SR;5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxy phenyl)-2-isopropylvaleronitrile hydrochloride;Akilen;VERAPAMIL HYDROCHLORIDE [USP-RS];alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile hydrochloride (1:1);CCG-39491;FT-0655647;LU 20175;Geangin;Verapamyl hydrochloride;Verapamil.HCl, 1mg/ml in Methanol;Berkatens;Manidon Retard;CHEMBL1280;LP01237;SR-01000000050-11;(+/-)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material;rac-2-(3,4-dimethoxyphenyl)-5-((2-(3,4-dimethoxyphenyl)ethyl)(methyl)amino)-2-isopropylpentanenitrile hydrochloride;Veramex;TARKA COMPONENT VERAPAMIL HYDROCHLORIDE;Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-, monohydrochloride;Verapamil hydrochloride [USAN:USP:JAN];Vera-Sanorania;VERAPAMIL HYDROCHLORIDE (USP-RS);Civicor Retard;C27H38N2O4.HCl;Hydrochloride, Verapamil;HY-A0064;BV164516;EU-0101237;Covera-hs (TN);Dignover;NSC759589;Verapamil MSD;Nor Verapamil-d6 Hydrochloride;VERAPAMIL HYDROCHLORIDE [MI];Univer;DTXSID2034095;VERAPAMIL HYDROCHLORIDE [EP IMPURITY];Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride;Isoptine;5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride;Verapamil NM;VERAPAMIL HYDROCHLORIDE [JAN];Verapamil Atid;HB1237;Verapamil hydrochloride (USAN:USP:JAN);Verapamil AL;Verpamil;(y)-Verapamil hydrochloride;SCHEMBL33296;NCGC00094479-01;AC-16228;VERAPAMILI HYDROCHLORIDUM [WHO-IP LATIN];VERAPAMIL HYDROCHLORIDE COMPONENT OF TARKA;SW196662-4;Verelan (TN);Iproveratril hydrochloride;D88195;NSC-272366;Novo-Veramil;VERAPAMIL HYDROCHLORIDE [VANDF];Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard;Verapamil-AbZ;Isoptin SR;FT-0630593;2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}-2-(methy lethyl)pentanenitrile, chloride;NCGC00094479-04;Verapamil NM Pharma;(2RS)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile monohydrochloride;CS-1685;Verapamil hydrochloride (JP17/USP);Z1557407143;2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-isopropylpentanenitrile hydrochloride;Verapamil.HCl, 1mg/ml in Methanol (as free base);2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride;Verapamil hydrochloride (JP18/USP);Verapamil (hydrochloride) (Standard);Verapamil HCl - Bio-X trade mark;R(+)-VERAPAMIL;205-800-5;HY-A0064R;ARD10701A;FV28686;?-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-?-(1-methylethyl)-benzeneacetonitrile hydrochloride;Berkatens; Calan;(+/-)-Verapamil hydrochloride D7;

MFCD00055208

DOQPXTMNIUCOSY-UHFFFAOYSA-N

1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H

Cl.O(C)C1=C(C=CC(=C1)C(C#N)(CCCN(C)CCC1C=CC(=C(C=1)OC)OC)C(C)C)OC

205-800-5

2926909090

用于有机合成、医药工业;主要用于阵发性室上性心动过速,也用于心绞痛、高血压和肥厚型梗塞性心肌病

3647093

3647093